Question 5 of 9 Which frequency of testing should take place for the patient taking cabotegravir for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)?Every 3 monthsEvery 12 monthsOnce before beginning PrEPAfter each contact that puts the patient at risk for infection
[Answered]: of 9 Which frequency of testing should take place…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.